Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079657186> ?p ?o ?g. }
- W2079657186 endingPage "e47891" @default.
- W2079657186 startingPage "e47891" @default.
- W2079657186 abstract "A defined diagnostic panel differentiated patients who had been diagnosed with chronic fatigue syndrome (CFS), based upon Fukuda/Carruthers criteria. This diagnostic panel identified an Epstein-Barr virus (EBV) subset of patients (6), excluding for the first time other similar clinical conditions such as cytomegalovirus (CMV), human herpesvirus 6 (HHV6), babesiosis, ehrlichiosis, borreliosis, Mycoplasma pneumoniae, Chlamydia pneumoniae, and adult rheumatic fever, which may be mistakenly called CFS. CFS patients were treated with valacyclovir (14.3 mg/kg q6h) for ≥ 12 months. Each patient improved, based upon the Functional Activity Appraisal: Energy Index Score Healthcare Worker Assessment (EIPS), which is a validated (FSS-9), item scale with high degree of internal consistency measured by Cronbach's alpha.Antibody to EBV viral capsid antigen (VCA) IgM, EBV Diffuse Early Antigen EA(D), and neutralizing antibodies against EBV-encoded DNA polymerase and EBV-encoded dUTPase were assayed serially approximately every three months for 13-16 months from sera obtained from patients with CFS (6) and from sera obtained from twenty patients who had no history of CFS.Antibodies to EBV EA(D) and neutralizing antibodies against the encoded-proteins EBV DNA polymerase and deoxyuridine triphosphate nucleotidohydrolase (dUTPase) were present in the EBV subset CFS patients. Of the sera samples obtained from patients with CFS 93.9% were positive for EA(D), while 31.6% of the control patients were positive for EBV EA(D). Serum samples were positive for neutralizing antibodies against the EBV-encoded dUTPase (23/52; 44.2%) and DNA polymerase (41/52; 78.8%) in EBV subset CFS patients, but negative in sera of controls.There is prolonged elevated antibody level against the encoded proteins EBV dUTPase and EBV DNA polymerase in a subset of CFS patients, suggesting that this antibody panel could be used to identify these patients, if these preliminary findings are corroborated by studies with a larger number of EBV subset CFS patients." @default.
- W2079657186 created "2016-06-24" @default.
- W2079657186 creator A5001710528 @default.
- W2079657186 creator A5011987994 @default.
- W2079657186 creator A5016090007 @default.
- W2079657186 creator A5029825214 @default.
- W2079657186 creator A5074700984 @default.
- W2079657186 creator A5077984302 @default.
- W2079657186 creator A5078708055 @default.
- W2079657186 creator A5079925512 @default.
- W2079657186 date "2012-11-14" @default.
- W2079657186 modified "2023-10-02" @default.
- W2079657186 title "Antibody to Epstein-Barr Virus Deoxyuridine Triphosphate Nucleotidohydrolase and Deoxyribonucleotide Polymerase in a Chronic Fatigue Syndrome Subset" @default.
- W2079657186 cites W1595961517 @default.
- W2079657186 cites W1967129227 @default.
- W2079657186 cites W1979542999 @default.
- W2079657186 cites W1979705133 @default.
- W2079657186 cites W1979976650 @default.
- W2079657186 cites W1980464074 @default.
- W2079657186 cites W1980883102 @default.
- W2079657186 cites W1980907514 @default.
- W2079657186 cites W1982249239 @default.
- W2079657186 cites W1984153291 @default.
- W2079657186 cites W1987094938 @default.
- W2079657186 cites W1995582130 @default.
- W2079657186 cites W1999438426 @default.
- W2079657186 cites W2006525633 @default.
- W2079657186 cites W2008087869 @default.
- W2079657186 cites W2016920052 @default.
- W2079657186 cites W2025444958 @default.
- W2079657186 cites W2029988735 @default.
- W2079657186 cites W2037024023 @default.
- W2079657186 cites W2068813825 @default.
- W2079657186 cites W2072421028 @default.
- W2079657186 cites W2086119541 @default.
- W2079657186 cites W2089750010 @default.
- W2079657186 cites W2098287790 @default.
- W2079657186 cites W2110242833 @default.
- W2079657186 cites W2115275509 @default.
- W2079657186 cites W2121224871 @default.
- W2079657186 cites W2145158104 @default.
- W2079657186 cites W2145212803 @default.
- W2079657186 cites W2148889688 @default.
- W2079657186 cites W2151781175 @default.
- W2079657186 cites W2168833309 @default.
- W2079657186 cites W2169857558 @default.
- W2079657186 cites W2170125822 @default.
- W2079657186 cites W2327956054 @default.
- W2079657186 doi "https://doi.org/10.1371/journal.pone.0047891" @default.
- W2079657186 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3498272" @default.
- W2079657186 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23155374" @default.
- W2079657186 hasPublicationYear "2012" @default.
- W2079657186 type Work @default.
- W2079657186 sameAs 2079657186 @default.
- W2079657186 citedByCount "40" @default.
- W2079657186 countsByYear W20796571862012 @default.
- W2079657186 countsByYear W20796571862013 @default.
- W2079657186 countsByYear W20796571862014 @default.
- W2079657186 countsByYear W20796571862015 @default.
- W2079657186 countsByYear W20796571862016 @default.
- W2079657186 countsByYear W20796571862017 @default.
- W2079657186 countsByYear W20796571862018 @default.
- W2079657186 countsByYear W20796571862019 @default.
- W2079657186 countsByYear W20796571862020 @default.
- W2079657186 countsByYear W20796571862021 @default.
- W2079657186 countsByYear W20796571862022 @default.
- W2079657186 countsByYear W20796571862023 @default.
- W2079657186 crossrefType "journal-article" @default.
- W2079657186 hasAuthorship W2079657186A5001710528 @default.
- W2079657186 hasAuthorship W2079657186A5011987994 @default.
- W2079657186 hasAuthorship W2079657186A5016090007 @default.
- W2079657186 hasAuthorship W2079657186A5029825214 @default.
- W2079657186 hasAuthorship W2079657186A5074700984 @default.
- W2079657186 hasAuthorship W2079657186A5077984302 @default.
- W2079657186 hasAuthorship W2079657186A5078708055 @default.
- W2079657186 hasAuthorship W2079657186A5079925512 @default.
- W2079657186 hasBestOaLocation W20796571861 @default.
- W2079657186 hasConcept C126322002 @default.
- W2079657186 hasConcept C159047783 @default.
- W2079657186 hasConcept C159654299 @default.
- W2079657186 hasConcept C203014093 @default.
- W2079657186 hasConcept C2522874641 @default.
- W2079657186 hasConcept C2779566273 @default.
- W2079657186 hasConcept C2781375147 @default.
- W2079657186 hasConcept C71924100 @default.
- W2079657186 hasConceptScore W2079657186C126322002 @default.
- W2079657186 hasConceptScore W2079657186C159047783 @default.
- W2079657186 hasConceptScore W2079657186C159654299 @default.
- W2079657186 hasConceptScore W2079657186C203014093 @default.
- W2079657186 hasConceptScore W2079657186C2522874641 @default.
- W2079657186 hasConceptScore W2079657186C2779566273 @default.
- W2079657186 hasConceptScore W2079657186C2781375147 @default.
- W2079657186 hasConceptScore W2079657186C71924100 @default.
- W2079657186 hasIssue "11" @default.
- W2079657186 hasLocation W20796571861 @default.
- W2079657186 hasLocation W20796571862 @default.
- W2079657186 hasLocation W20796571863 @default.
- W2079657186 hasLocation W20796571864 @default.